This is very substantial announcement indeed..
Can $2 with not product and now has product should edge back to that mark..
i will say I am surprised by the lack of interest in our partners who have the licenses in Australia and abroad to manufacture and package these medicinal high potency products
Both party’s benefit significantly here
CAN & IDT are very well positioned for growth from this dealIDT’s solvent extraction facilities and capabilities have been successfully utilised in respect of cannabis cultivars.
This represents the first commercial-scale resin extraction from Australian grown cultivars
The extracted resin will be formulated into a full range of GMP medicinal cannabis finished dosage form products, including formulations featuring high THC, high CBD and balanced formulations. These products will be formulated and packed by IDT and made available via the Special Access Scheme (SAS) to Australian prescribers and patients, and will be positioned for export to markets overseas
- Forums
- ASX - By Stock
- Ann: Commercial-scale GMP medicinal cannabis resin extraction
This is very substantial announcement indeed..Can $2 with not...
-
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CAN (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.74M |
Open | High | Low | Value | Volume |
3.8¢ | 3.8¢ | 3.8¢ | $114 | 2.995K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 104975 | 3.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.9¢ | 30500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 104975 | 0.038 |
4 | 382482 | 0.037 |
3 | 74351 | 0.036 |
5 | 4035800 | 0.035 |
4 | 72094 | 0.034 |
Price($) | Vol. | No. |
---|---|---|
0.039 | 30500 | 1 |
0.040 | 14285 | 1 |
0.041 | 90000 | 1 |
0.042 | 310000 | 2 |
0.044 | 300000 | 1 |
Last trade - 10.02am 10/09/2024 (20 minute delay) ? |
Featured News
CAN (ASX) Chart |